Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Sudhakar R. Subramaniam, Marie‐Françoise Chesselet
Progress in Neurobiology (2013) Vol. 106-107, pp. 17-32
Open Access | Times Cited: 737

Showing 1-25 of 737 citing articles:

Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
Lauren E. Tebay, Holly Robertson, Stephen T. Durant, et al.
Free Radical Biology and Medicine (2015) Vol. 88, pp. 108-146
Open Access | Times Cited: 742
Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease
Tianfang Jiang, Qian Sun, Shengdi Chen
Progress in Neurobiology (2016) Vol. 147, pp. 1-19
Closed Access | Times Cited: 548
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff, Geewoo Nam, Juhye Kang, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1221-1322
Closed Access | Times Cited: 479
Protective and toxic roles of dopamine in Parkinson's disease
Juan Segura‐Aguilar, Irmgard Paris, Patricia Muñoz, et al.
Journal of Neurochemistry (2014) Vol. 129, Iss. 6, pp. 898-915
Closed Access | Times Cited: 434
Mitochondrial Dysfunction in Parkinson’s Disease
Hyo Eun Moon, Sun Ha Paek
Experimental Neurobiology (2015) Vol. 24, Iss. 2, pp. 103-116
Open Access | Times Cited: 345
Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review)
Ji‐Dong Guo, Xin Zhao, Yang Li, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 280
Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do, Cindy E. McKinney, Pankaj Sharma, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 247
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
Gargi Ganguly, Sasanka Chakrabarti, Uttara Chatterjee, et al.
Drug Design Development and Therapy (2017) Vol. Volume11, pp. 797-810
Open Access | Times Cited: 241
Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders
Fabio Di Domenico, Antonella Tramutola, D. Allan Butterfield
Free Radical Biology and Medicine (2016) Vol. 111, pp. 253-261
Closed Access | Times Cited: 224
Review: Environmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience‐dependent plasticity
Anthony J. Hannan
Neuropathology and Applied Neurobiology (2013) Vol. 40, Iss. 1, pp. 13-25
Closed Access | Times Cited: 222
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
Toshiki Uchihara, Benoit I. Giasson
Acta Neuropathologica (2015) Vol. 131, Iss. 1, pp. 49-73
Open Access | Times Cited: 210
Parkinson's disease as a result of aging
Manuel Rodrı́guez, Clara Rodriguez‐Sabate, Ingrid Moráles, et al.
Aging Cell (2015) Vol. 14, Iss. 3, pp. 293-308
Open Access | Times Cited: 201
The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction
Yuri Zilberter, Misha Zilberter
Journal of Neuroscience Research (2017) Vol. 95, Iss. 11, pp. 2217-2235
Open Access | Times Cited: 192
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen Xu, Yong Chen, Yang Xu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 192
Communication between mitochondria and other organelles: a brand-new perspective on mitochondria in cancer
Mengfang Xia, Yazhuo Zhang, Ke Jin, et al.
Cell & Bioscience (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 184
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xiansi Zeng, Wen-Shuo Geng, Jing Jia, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 178
Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration
Xinxin Ma, Junnian Hao, Jianrong Wu, et al.
Advanced Materials (2022) Vol. 34, Iss. 15
Closed Access | Times Cited: 165
Oxidative stress factors in Parkinson’s disease
Jolanta Dorszewska, Marta Kowalska, Michał Prendecki, et al.
Neural Regeneration Research (2020) Vol. 16, Iss. 7, pp. 1383-1383
Open Access | Times Cited: 143
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
Annika Höhn, Antonella Tramutola, Roberta Cascella
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 138
Alpha-Synuclein Aggregation in Parkinson's Disease
E. Srinivasan, G. Chandrasekhar, P. Chandrasekar, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 117
Metals associated neurodegeneration in Parkinson’s disease: Insight to physiological, pathological mechanisms and management
Khadga Raj, Pawandeep Kaur, Ghanshyam Das Gupta, et al.
Neuroscience Letters (2021) Vol. 753, pp. 135873-135873
Closed Access | Times Cited: 115
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 114
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 63
Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson’s disease
Qingqing Shen, Xian-hui Jv, Xizhen Ma, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 2, pp. 268-281
Closed Access | Times Cited: 49
The reciprocal interactions between microglia and T cells in Parkinson’s disease: a double-edged sword
Yuxiang Xu, Yongjie Li, Changqing Wang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top